Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampligen with FluMist in Healthy Volunteers
NCT01591473Phase 2Terminated
- Sponsor
- AIM ImmunoTech
- Start
- Apr 2012
- Primary completion
- Sep 2014
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of rintatolimod in influenza, sponsored by AIM ImmunoTech. Started Apr 2012; status: terminated.
02
Drugs
rintatolimod
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01591473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01591473.